ReviewJournal of cardiovascular imaging2026
Women's heart and echocardiography.
Review in Journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Echocardiography is the primary imaging modality for evaluating cardiovascular disease, providing comprehensive assessment of cardiac structure, function, and hemodynamics. Its noninvasive nature, wide availability, and absence of radiation make it particularly suitable for repeated use, including in younger women and during pregnancy. Moreover, women-specific cardiovascular diseases are not uncommonly detected by echocardiography. However, smaller cardiac size, higher baseline ejection fraction, and technical limitations in women may affect interpretation. This review highlights the role of echocardiography across cardiovascular conditions relevant to women, including heart failure with preserved ejection fraction, coronary microvascular dysfunction, pulmonary hypertension, and valvular heart disease. It also addresses stress-induced cardiomyopathy, physiological changes during pregnancy, and peripartum cardiomyopathy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.